September 17th, 2012
Selections from Richard Lehman’s Literature Review: September 17th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include surgical vs. lifestyle treatment for type-2 diabetes, omega-3 fatty-acid supplementation and the risk for major CVD events, FAME 2, using high-sensitivity cardiac troponin T for one-hour rule-out or rule-in of acute MI, and the timing of acute MI in patients having total hip or knee replacement.
August 20th, 2010
A “Good” Heart…
John Mandrola, MD, FACC
John Mandrola, an electrophysiologist and avid cyclist, usually writes about cycling in the Wednesday posts to his blog, Dr. John. Here he examines how antagonism relates to carotid thickness. This Wednesday, it will be easy to combine cycling and medicine. When I saw this study that linked antagonistic personality traits and cardiovascular risk, it was simply impossible […]
August 10th, 2010
A Family Affair
Juan J. Rivera, MD, MHS
The surplus of specialists and neglect of primary and preventive care in modern American medicine has led to a very sharp focus on individuals, with little regard for families. A perfect example of how this imbalance has detrimental effects at the population level is the childhood obesity epidemic. Many healthcare professionals perceive obesity as an […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?